Posts by InovaNewsroom
Inova Schar Heart and Vascular receives $1.4 million pediatric heart transplant research grant
Fairfax, VA — A research team at Inova Schar Heart and Vascular recently received nearly $1.4 million to develop a new blood test that doctors can use to optimize the immunosuppression medications needed after pediatric heart transplant. The team will be led by Palak Shah, MD, MS, Director of the Inova Cardiovascular Genomics Center and…
Read MoreInova plays a key role in trial of innovative treatment for tricuspid valve regurgitation that is now approved by the FDA
Update as of April 24, 2024: Inova’s structural heart team has now completed the first case in the Washington, DC region since the FDA approved a new device to treat tricuspid regurgitation (TR). Inova Schar Heart and Vascular’s Structural Heart/Valve Disease Program was among the top enrollers in the TRILUMINATE™ Pivotal Trial demonstrating the safety…
Read MoreInova receives $20 million gift from the Peterson Family to support critical needs
Fairfax, VA, April 16, 2024 – Inova today announced a transformational gift of $20 million from the Peterson Family, longtime Inova supporters. This donation will provide funding for two critical needs, with $15 million going to Inova Life with Cancer, and $5 million to support the expansion of the Inova Fairfax Emergency Room. “We are…
Read MoreMindful, intuitive eating for health: ditching the diet and feeding the soul
Lauren Trahan, MS, RD is a Registered Dietitian. She serves patients in Inova Cardiac and Pulmonary Rehabilitation. Losing weight can lower your blood pressure, reduce your cholesterol levels and decrease your chances of developing diabetes – all of which are risk factors for heart disease and stroke. The easiest way to lose weight and keep…
Read MoreInova Schar Cancer named top recruiter to innovative ER+ HER2- breast cancer clinical trial
Inova Schar Cancer is one of the top recruiting locations for the EMBER-4 clinical trial, a global study to evaluate a new treatment for ER+ HER2- breast cancer survivors EMBER-4 is a Phase 3 clinical trial comparing a new drug therapy, imlunestrant, to the standard drug therapy to treat women with ER+ HER2- breast cancer.…
Read MoreInova partners with ChartSpan to elevate chronic care management for patients
Fairfax, VA – March 26, 2024 – Inova Health System and ChartSpan, a leading provider of Chronic Care Management (CCM) solutions, announced a strategic partnership aimed at enhancing the delivery of chronic care management services to patients in Northern Virginia and the Washington, DC metropolitan area. This collaborative effort combines ChartSpan’s dedicated Chronic Care Management…
Read MoreInova Cares for Behavioral Health expands patient criteria
Adolescents 14 years and older now eligible Leesburg, VA — Inova Cares for Behavioral Health (ICBH) is now accepting adolescent patients 14 years and older with mild to moderate mental health challenges including stress, anxiety, grief and depression. ICBH provides mental health counseling services to adolescents and adults who are uninsured and eligible for Inova’s Financial…
Read MoreInova Announces $10 Million Planned Gift Commitment from Win Sheridan
Falls Church, VA, March 21, 2024 – Inova today announced that it has received a $10 million planned gift commitment from Win Sheridan, co-founder of APEX Systems, to be applied towards the health system’s Greatest Needs fund. This fund is disbursed at the discretion of the CEO for critical projects and initiatives. “Every gift to…
Read MoreInova Health Equity Opportunities accepting 2024 applications
Falls Church, VA — Inova is dedicated to supporting programs and opportunities that make a difference in the quality of life, health and welfare of our under-resourced communities. Inova is now accepting Inova Health Equity Opportunities applications from local non-profit community partners for projects aligned with our Community Health Needs Assessments related to behavioral health,…
Read MoreBESPOKE clinical trial supports value of blood test for colon cancer recurrence
The BESPOKE clinical trial evaluated molecular markers in blood samples as a guide that physicians can use to determine the benefit of chemotherapy for stage II and III colon cancer According to the Centers for Disease Control and Prevention, more than 126,000 new cases of colon cancer (colorectal cancer) were diagnosed in 2020. Colon cancer…
Read More